Literature DB >> 35015088

[Cardiogenic shock complicating myocardial infarction].

Karl Werdan1,2, Markus Wolfgang Ferrari3, Roland Prondzinsky4, Martin Ruß5.   

Abstract

Cardiogenic shock as a complication of myocardial infarction (5-10%) increases the mortality of uncomplicated myocardial infarction from less than 10% to 40%. This is due to the development of multiple organ dysfunction syndrome triggered by the extensive shock-induced impairment of organ perfusion. Therefore, guideline-based treatment should not only be restricted to reopening of the occluded coronary artery and management of complications of the infarction: important for survival are also guideline-driven optimization of organ perfusion by inotropic and vasoactive substances and, with well-defined indications, by temporary mechanical circulatory support but not by intra-aortic counterpulsation. Equally important, however, are shock-specific intensive care measures to prevent or attenuate organ dysfunction, such as lung protective ventilation in cases where ventilation is obligatory.
© 2021. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Guidelines; Intra-aortic balloon counterpulsation; Multiple organ failure; Percutaneous coronary intervention; Temporary mechanical support

Mesh:

Year:  2022        PMID: 35015088     DOI: 10.1007/s00059-021-05088-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  36 in total

Review 1.  Impact of access site choice on outcomes of patients with cardiogenic shock undergoing percutaneous coronary intervention: A systematic review and meta-analysis.

Authors:  Samir B Pancholy; Ghanshyam Palamaner Subash Shantha; Enrico Romagnoli; Sasko Kedev; Ivo Bernat; Sunil V Rao; Sanjit Jolly; Olivier F Bertrand; Tejas M Patel
Journal:  Am Heart J       Date:  2015-05-07       Impact factor: 4.749

2.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.

Authors:  Holger Thiele; Ibrahim Akin; Marcus Sandri; Georg Fuernau; Suzanne de Waha; Roza Meyer-Saraei; Peter Nordbeck; Tobias Geisler; Ulf Landmesser; Carsten Skurk; Andreas Fach; Harald Lapp; Jan J Piek; Marko Noc; Tomaž Goslar; Stephan B Felix; Lars S Maier; Janina Stepinska; Keith Oldroyd; Pranas Serpytis; Gilles Montalescot; Olivier Barthelemy; Kurt Huber; Stephan Windecker; Stefano Savonitto; Patrizia Torremante; Christiaan Vrints; Steffen Schneider; Steffen Desch; Uwe Zeymer
Journal:  N Engl J Med       Date:  2017-10-30       Impact factor: 91.245

3.  The diagnostic accuracy of clinical examination for estimating cardiac index in critically ill patients: the Simple Intensive Care Studies-I.

Authors:  Bart Hiemstra; Geert Koster; Renske Wiersema; Yoran M Hummel; Pim van der Harst; Harold Snieder; Ruben J Eck; Thomas Kaufmann; Thomas W L Scheeren; Anders Perner; Jørn Wetterslev; Anne Marie G A de Smet; Frederik Keus; Iwan C C van der Horst
Journal:  Intensive Care Med       Date:  2019-01-31       Impact factor: 17.440

4.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Antoinette de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Bernward Lauer; Michael Böhm; Henning Ebelt; Steffen Schneider; Karl Werdan; Gerhard Schuler
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

5.  Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.

Authors:  Bruno Levy; Raphael Clere-Jehl; Annick Legras; Tristan Morichau-Beauchant; Marc Leone; Ganster Frederique; Jean-Pierre Quenot; Antoine Kimmoun; Alain Cariou; Johan Lassus; Veli-Pekka Harjola; Ferhat Meziani; Guillaume Louis; Patrick Rossignol; Kevin Duarte; Nicolas Girerd; Alexandre Mebazaa; Philippe Vignon
Journal:  J Am Coll Cardiol       Date:  2018-07-10       Impact factor: 24.094

6.  Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Henning Ebelt; Steffen Schneider; Gerhard Schuler; Karl Werdan
Journal:  N Engl J Med       Date:  2012-08-26       Impact factor: 91.245

7.  Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology.

Authors:  Uwe Zeymer; Hector Bueno; Christopher B Granger; Judith Hochman; Kurt Huber; Maddalena Lettino; Susanna Price; Francois Schiele; Marco Tubaro; Pascal Vranckx; Doron Zahger; Holger Thiele
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-03-02

8.  Infarction-Related Cardiogenic Shock- Diagnosis, Monitoring and Therapy–A German-Austrian S3 Guideline.

Authors:  Karl Werdan; Michael Buerke; Alexander Geppert; Holger Thiele; Bernd Zwissler; Martin Ruß
Journal:  Dtsch Arztebl Int       Date:  2021-02-12       Impact factor: 5.594

Review 9.  The German-Austrian S3 Guideline "Cardiogenic Shock Due to Myocardial Infarction: Diagnosis, Monitoring, and Treatment".

Authors:  Kevin Pilarczyk; Karl Werdan; Martin Russ; Holger Thiele; Guido Michels; Udo Boeken; Matthias Thielmann
Journal:  Thorac Cardiovasc Surg       Date:  2020-12-24       Impact factor: 1.827

10.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.

Authors:  Karl Heinrich Scholz; Sebastian K G Maier; Lars S Maier; Björn Lengenfelder; Claudius Jacobshagen; Jens Jung; Claus Fleischmann; Gerald S Werner; Hans G Olbrich; Rainer Ott; Harald Mudra; Karlheinz Seidl; P Christian Schulze; Christian Weiss; Josef Haimerl; Tim Friede; Thomas Meyer
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.